The Biostatistics Core Facility is a shared resource to provide statistical and data management support to the Case Comprehensive Cancer Center (Case CCC). The core includes biostatistical and data management staff and consultants from Case Western Reserve University (Case), Ireland Cancer Center at University Hospitals (UH), and the Taussig Cancer Center at the Cleveland Clinic. It brings together individuals with expertise and intellectual resources in 1) biostatistics, 2) clinical trials, 3) epidemiology, 4) statistical computing, and 5) database and information management. The members of this shared resource have a commitment to collaboration with Cancer Center member investigators, applying the discipline of biostatistics to support cancer research and education. The core facility has wide involvement in support of research at the Cancer Center. Activities of this core facility include: 1) design of studies (clinical trials and others) and protocol development;2) protocol review;3) data analysis and reporting;4) manuscript preparation and review;5) database development and management;6) trial monitoring;and 7) education for members of the Case CCC in study design, research methods, data collection, and statistical methods for laboratory-based and clinical studies. Specialized analytic support is also available for gene expression studies, and analysis of large databases. The core facility closely supports activities of the Clinical Trials Core Facility in planning studies, collecting and editing data, monitoring trials, and analyzing results. The Biostatistics Core also interacts with the Behavioral Measurement Core Facility to integrate measurement development and analysis tasks, as well as with biostatisticians providing statistical genetics expertise to the Cancer Genetics Program. Coordination of core functions and utilization occurs through regular meetings of key personnel from Case/UH, Ireland Cancer Center, and the Taussig Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-20
Application #
7799311
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
20
Fiscal Year
2009
Total Cost
$814,669
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Benson, Bryan L; Li, Lucy; Myers, Jay T et al. (2018) Biomimetic post-capillary venule expansions for leukocyte adhesion studies. Sci Rep 8:9328
Bosca, Federica; Bielecki, Peter A; Exner, Agata A et al. (2018) Porphyrin-Loaded Pluronic Nanobubbles: A New US-Activated Agent for Future Theranostic Applications. Bioconjug Chem 29:234-240
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 63:1449-1453
Morrow, James J; Bayles, Ian; Funnell, Alister P W et al. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med 24:176-185
Anderson, Christian E; Wang, Charlie Y; Gu, Yuning et al. (2018) Regularly incremented phase encoding - MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting. Magn Reson Med 79:2176-2182
Burger, Denis R; Parker, Yvonne; Guinta, Kathryn et al. (2018) PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice. Biol Blood Marrow Transplant 24:260-266
Shi, Xiaojun; Wang, Bingcheng (2018) Caught in the ""Akt"": Cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF. Sci Signal 11:
Tartakoff, Alan Michael; Dulce, David; Landis, Elizabeth (2018) Delayed Encounter of Parental Genomes Can Lead to Aneuploidy in Saccharomyces cerevisiae. Genetics 208:139-151
Gromovsky, Anthony D; Schugar, Rebecca C; Brown, Amanda L et al. (2018) ?-5 Fatty Acid Desaturase FADS1 Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators. Arterioscler Thromb Vasc Biol 38:218-231
Ignatz-Hoover, James J; Wang, Victoria; Mackowski, Nathan M et al. (2018) Aberrant GSK3? nuclear localization promotes AML growth and drug resistance. Blood Adv 2:2890-2903

Showing the most recent 10 out of 1227 publications